Hugo del Castillo

Dr. Hugo del Castillo

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2014 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
DKDita Kopecna
Dita Kopecna
SFSem Briongos Figuero
Sem Briongos Figuero
HCHugo del Castillo
Hugo del Castillo
CMCarlos Moreno
Carlos Moreno
MRMónica Recio
Mónica Recio
FIfor the PROTECT investigators
for the PROTECT investigators
To evaluate the interobserver reliability of echocardiographic findings of right ventricle (RV) dysfunction for prognosticating normotensive patients with pulmonary embolism (PE). A central panel of cardiologists evaluated echocardiographic studies of 75 patients included in the PROTECT study for the following signs: RV diameter, RV/left ventricular (LV) diameter ratio, hypokinesis of the RV free wall, and tricuspid plane systolic excursion (TAPSE). Investigators used intraclass correlation to assess agreement between the measurements of the central panel and each of the local cardiologists. Investigators used the single weighted kappa statistic to test for agreement between readers of interpretation of RV enlargement and RV hypokinesis. The two observers had fair agreement (k = 0.45) for RV enlargement assessed by the RV diameter, and good agreement (k = 0.65) for RV enlargement assessed by the RV/LV diameter ratio. The interobserver reliability of the assessment whether hypokinesis of the RV free wall is present was good (к = 0.70), and whether RV dysfunction (assessed by TAPSE measurement) is present was very good (k = 0.86). The intraclass correlation for the RV/LV diameter ratio was fair (0.55; 95% confidence interval [CI], 0.37-0.69), for the RV diameter was good (0.70; 95% CI, 0.56-0.80), and for the TAPSE measurement was very good (0.85; 95% CI, 0.77-0.90). On Bland-Altman analysis, the mean differences for RV diameter, RV/LV diameter ratio and TAPSE measurement were 2.33 (±5.38), 0.06 (±0.23) and 0.08 (±2.20), respectively. TAPSE measurement is the least user dependent and most reproducible echocardiographic finding of RV dysfunction in normotensive patients with PE.

31 August 2013 in Current Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
HCHugo del Castillo
Hugo del Castillo
VAVivencio B. Alonso
Vivencio B. Alonso
JSJosé Sabán-Ruiz
José Sabán-Ruiz
JGJosé L. Z. Gómez
José L. Z. Gómez
Platelet aggregation activity is the cornerstone of the pathogenesis of atherothrombosis and plays a main role in the appearance of major adverse cardiac events (MACE). This aspect has become even more important nowadays due to the use of drug-eluting stents (DES), where a proper platelet inhibition is required. Dual antiplatelet therapy with aspirin and clopidogrel in patients undergoing percutaneous coronary intervention (PCI) has widely demonstrated its beneficial effect in reducing MACE compared with aspirin alone. These benefits had also been established in short and long term treatment in patients with coronary artery disease managed with a conservative strategy. However, despite dual antiplatelet therapy an important number of patients experience new MACE related to an incomplete platelet inhibition that can be caused by the interaction of different mechanisms, not fully known at the moment. Several clinical studies suggested the significant variability in individual patient response to antiplatelet drugs to be due to the use of different laboratory tests. Moreover, other studies associated the low responsiveness status with an increased risk of recurrent cardiovascular events. Notably, resistance or reduced response to antiplatelet therapy with aspirin and clopidogrel is a clinically relevant entity that needs to be taken into account in order to perform a proper and individualized treatment strategy. Recent antiplatelet drugs such as prasugrel and ticagrelor have appeared to be an attractive option for patients with resistance or low response to traditional therapy. In this article we review aspirin and clopidogrel resistance as a clinical entity, the different mechanisms that could be linked to treatment failure, its relation with special situations and future perspectives in this area.

1 September 2014 in Medicina Clinica
Verified
Journal Article
Closed access
HCHugo del Castillo
Hugo del Castillo
VAVivencio Barrios Alonso
Vivencio Barrios Alonso
JGJosé Luis Zamorano Gómez
José Luis Zamorano Gómez

26 June 2012 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
HCHugo del Castillo
Hugo del Castillo
MVMónica Recio Vázquez
Mónica Recio Vázquez
JMJosé Luis Moya Mur
José Luis Moya Mur
VAVivencio Barrios Alonso
Vivencio Barrios Alonso
JZJosé L. Zamorano
José L. Zamorano

15 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HCHugo del Castillo
Hugo del Castillo
JGJosé M. Gámez
José M. Gámez
Background/Objectives: The COVID-19 pandemic caused healthcare managers to reallocate resources from other areas in order to handle the outbreak. Cardiovascular usual care was especially affected during the first wave. Methods: We analyzed the short- and mid-term impact of the resource reallocation on cardiovascular health, focusing on the Balearic Islands in Spain. Data from 2019 to 2021 of the regional healthcare system and from the national and regional stats center were collected in order to analyze the variations in type of admissions, main causes of cardiovascular mortality, and the correlation between the monthly variation in those causes of mortality and total cardiovascular mortality. Results: The year 2021 showed worse results in terms of healthcare outcomes compared to the pre-pandemic period, with a population-adjusted cardiovascular mortality increase of 4.8% and heart failure and hypertension being the main drivers (6.4% and 26.45%, respectively). However, this impact was not homogeneous in both pandemic years. In 2020, the main driver for the cardiovascular mortality increase was myocardial infarction (R Pearson = 0.655/p = 0.021). On the other hand, chronic conditions such as heart failure and hypertension led to the increase in cardiovascular mortality in 2021 (R Pearson = 0.671/p = 0.017 and R Pearson = 0.619/p = 0.032, respectively). In-hospital resources for COVID-19 showed a positive correlation to cardiovascular mortality in 2021; however, it did not reach statistical significance (R Pearson = 0.41/p = 0.1). Conclusions: Mid-term cardiovascular health worsened in the Spanish Balearic Island region, with hypertension and heart failure being the main drivers, with important differences in influence between 2020 and 2021. We found a correlation between COVID-19 in-hospital resource allocation and total cardiovascular mortality.